Blog

New submissions are welcome! Submit your research to the special issue on "Phage-antibiotic Combination Therapy" in Viruses. I will be serving as a guest editor. https://www.mdpi.com/journal/viruses/special_issues/62FG2XW90A Dear Colleagues, Antibiotic resistance…

A new article, "Adjunctive phage therapy improves antibiotic treatment of ventilator-associated pneumonia with Pseudomonas aeruginosa" Abstract Bacterial multidrug resistance poses an urgent challenge for the treatment of critically ill patients developing…

Bacteriophages (phages) are viruses that selectively target and kill bacteria. They are the most abundant, commonly occurring natural entities, playing crucial roles in regulating bacterial populations and influencing microbial ecosystems.…

A new study reporting N15-like Klebsiella phage "Telomere bacteriophages are widespread and equip their bacterial hosts with potent interbacterial weapons" Abstract: Bacteriophages (phages) are viruses that can kill bacteria, thereby…

A new article from Yale University, Center for Phage Biology and Therapy. Personalized inhaled bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis Bacteriophage (phage) therapy, which uses lytic viruses…

Following a high-profile success in 2016, the field of phage therapy has been reinvigorated. Numerous biotechnology companies, academic groups, and hospitals are now developing and using phage to treat bacterial…

Endolysins—enzymes produced by tailed bacteriophages to degrade bacterial cell walls—have traditionally been classified as canonical or signal-anchor-release (SAR) endolysins. However, expanding viral (meta)genomic data analysis has revealed a third class,…

Researchers at Pitt have produced the most detailed image to date of a bacteriophage–phage for short–that has allowed them to see for the first time the structural makeup of the…

A tool to identify suitable phage candidates for phage therapy. "Sphae: an automated toolkit for predicting phage therapy candidates from sequencing data" Abstract: The authors say "We developed Sphae, an…

Investigational Phage Therapy Shows Positive Topline Results for Diabetic Foot Osteomyelitis Yesterday, an Israeli-based company, BiomX, announced results from its phase 2 trial studying its investigational phage therapy, BX211, which…